logo

Exhibiting at HOTELEX Shanghai 2025

2.1D51
(NECC) in Hongqiao, West Shanghai
30 Mar - 2 Apr, 2025

Product Offerings

Products:

Core Equipment: Pressure Vessels, Heat Exchangers, Reactors

Process Systems: Modular Process Systems, Skid-mounted Units

Digital and Intelligent Engineering Solutions: Automation Systems, Smart Manufacturing Solutions

Morimatsu (China) Investment Co., Ltd. is the Chinese branch of Morimatsu Group, a global leader in process equipment manufacturing and integrated engineering solutions. Headquartered in Shanghai, the company is at the forefront of delivering advanced modular systems and core process equipment to the pharmaceutical, chemical, biotech, and energy sectors across China and internationally.

Core Business and Offerings

Morimatsu China provides end-to-end solutions encompassing the design, manufacturing, and integration of:

  • Core Equipment:

    • Pressure Vessels
    • Heat Exchangers
    • Chemical Reactors
  • Process Systems:

    • Modular Process Systems
    • Skid-mounted Processing Units
    • Pilot Plant Systems
  • Digital and Intelligent Engineering:

    • Industrial Automation and Control Systems
    • Smart Manufacturing Integration
    • Digital Twin and Data-driven Maintenance Solutions

These offerings are tailored to meet the complex process demands of high-tech industries requiring precision, safety, and efficiency.

Specialization and Unique Value Proposition

Morimatsu’s strength lies in its fusion of traditional manufacturing expertise with modern engineering and digital innovation. Key differentiators include:

  • Vertical Integration: From design to delivery and after-sales service
  • Modularization Technology: Enables rapid deployment, reduced footprint, and flexible scalability
  • Global Engineering Support: Backed by design centers and fabrication facilities in China, Japan, the USA, and Europe
  • Compliance Expertise: Adherence to global certifications and regional safety norms

Their modular solutions significantly reduce project timelines and installation costs while ensuring process accuracy and compliance.

Financials and Shipment Records

Morimatsu International Holdings Company Limited is listed on the Hong Kong Stock Exchange (HKEX: 2155), reporting:

  • Annual Revenue (2023): RMB 4.52 billion (~USD 630 million)
  • Net Profit: RMB 560 million (~USD 78 million)
  • R&D Investment: Over 5% of total revenue allocated annually

Trade databases like Volza and ImportYeti document over 2,000 international shipments from Morimatsu China over the last three years, including exports to North America, Southeast Asia, the Middle East, and Europe. Key exports include modular systems and customized pressure equipment.

Target Market

Morimatsu China serves a high-value industrial customer base across multiple sectors:

  • Pharmaceutical and Biotech
  • Petrochemical and Fine Chemicals
  • Energy and Environment
  • Food & Beverage Processing
  • New Energy (e.g., Hydrogen, Batteries)

Their clients range from multinational giants to regional engineering contractors requiring turnkey process systems.

Capabilities

  • Production Facilities: World-class factories in Shanghaintong, and other regions equipped with advanced CNC machining, welding, and testing equipment
  • R&D Centers: In-house laboratories and engineering teams focused on modularization, automation, and digital twins
  • Project Execution: Global project management systems ensuring cost control and timely delivery
  • Certifications:
    • ASME (U, U2, S stamps)
    • ISO 9001, ISO 14001, ISO 45001
    • PED (Europe), SELO (China)
    • GMP, FDA, and EU regulations compliance for pharma systems

Customer Testimonials

Although proprietary customer data is confidential, Morimatsu is a trusted partner to leading pharmaceutical and chemical companies globally. Client feedback highlights:

  • Reduction in project commissioning times by up to 30%
  • Up to 20% cost savings via modular plant deployment
  • 100% on-time delivery for critical systems during COVID-19 disruptions

Major Achievements

  • Listed on HKEX in 2020, marking a milestone in international capital markets
  • Awarded “Top 10 Modular Process System Providers” by China Chemical Equipment Association
  • Developed China’s first Digital Twin Pharmaceutical Plant in 2022
  • Over 10,000 modular and skid-mounted systems delivered globally
  • Strategic engineering partnerships with Pfizer, Bayer, BASF, and Sinopec

Morimatsu (China) Investment Co., Ltd. is redefining the landscape of process engineering with innovation-led solutions that drive productivity, sustainability, and compliance across global industries.